C ytosolic-free calcium (Ca 2ϩ ) is a multifunctional intracellular messenger that regulates many different cellular processes in cardiac myocytes. 1 4 and the Ca 2ϩ -CaM-dependent kinase II (CaMKII)-histone deacetylase (HDAC) pathways. 5 However, it remains a mystery exactly which subcellular Ca 2ϩ pools initiate these hypertrophic signaling and how these Ca 2ϩ -dependent signaling pathways are regulated in contracting cardiac myocytes given the highly specialized manner in which Ca 2ϩ concentration rhythmically cycles in E-C coupling. 6 It has been demonstrated previously that IP 3 R-mediated nuclear envelope Ca 2ϩ fluxes may activate Ca 2ϩ -CaM-CaMKII-HDAC5 signaling in ventricular myocytes, and the enhanced store-operated Ca 2ϩ entry into myocytes with overexpressed transient receptor protein C3 may increase NFAT transcriptional activity. 7 It was suggested that enhanced Ca 2ϩ release through IP 3 Rs may cause sensitization of RyR2s and a further increase in diastolic [Ca 2ϩ ] i . However, it is very controversial at present whether altered patterns of Ca 2ϩ release and reuptake associated with E-C coupling may affect hypertrophic signaling pathways and whether the diastolic SR Ca 2ϩ leak might also activate Ca 2ϩ -dependent hypertrophic signaling pathways under pathological conditions. 2, 6 Previous evidence from HF patients and animal models supports a functional role for enhanced diastolic Ca 2ϩ leak from SR through RyR2s in the development of contractile dysfunction. 8 In lipid bilayers, RyR2 phosphorylation caused FK506-binding protein 12.6 dissociation from the RyR2 and increased overall open probability of RyR2 channels. A variety of alterations in the subunits of the RyR2 macromolecular complex have been found in HF patients, including decreased levels of FK506-binding protein 12.6 (or calstabin2), protein phosphatases (1A and 2A), and phosphodiesterase 4D3. 8 In addition, changes in RyR2 posttranslational modifications, such as oxidation, S nitrosylation, and phosphorylation, have been shown in HF patients and animal models. 8 It was found that RyR2s were "hyperphosphorylated" by protein kinase A possibly because of the hyperadrenergic state and loss of RyR2-associated phosphatases (despite increased global phosphatases in cardiac myocytes). The combination of these alterations of RyR2 may lead to a decreased ability of the channel to remain closed during diastole, resulting in a net increase in diastolic SR proposed that enhanced SR Ca 2ϩ leak through "leaky" RyR2 Ca 2ϩ release channels during diastole may underlie contractile dysfunction. However, this attractive hypothesis has been seriously challenged by controversial findings on the effect of protein kinase A-dependent RyR phosphorylation during E-C coupling and the lack of supporting data in intact myocytes or whole-animal models. 3 In this issue of Hypertension, van Oort et al 9 used knockin (gain-of-function) mice heterozygous for mutation R176Q in RyR2 (R176Q/ϩ), which have been shown previously to increase SR Ca 2ϩ release in atrial and ventricular myocytes after catecholaminergic stimulation to specifically address the question of whether enhanced SR Ca 2ϩ leak through RyR2 accelerates the development of cardiac hypertrophy through the activation of Ca 2ϩ -dependent signaling pathways. They found that 8 weeks of transverse aortic constriction decreased systolic and diastolic heart functions and increased ventricular dimensions to a significantly larger extent in R176Q/ϩ mice when compared with wild-type mice. R176Q/ϩ mice displayed an enhanced hypertrophic response compared with wild-type mice as assessed by heart weight:body weight ratios and cardiomyocyte cross-sectional areas after transverse aortic constriction. Transverse aortic constriction pressure overload also resulted in an increased SR Ca 2ϩ leak, associated with higher expression levels of the exon 4 splice form of regulator of calcineurin 1 in R176Q/ϩ mice compared with wild-type mice. Therefore, the authors concluded that RyR2-dependent SR Ca 2ϩ leak may activate the prohypertrophic calcineurin/NFAT pathway during pressure overload (Figure) . These findings provide convincing in vivo evidence that increased RyR2-mediated Ca 2ϩ release from the SR is able to activate Ca 2ϩ -dependent hypertrophic signaling pathways, preferentially the calcineurin/ NFAT signaling pathway, under conditions of pressure overload. These novel findings are consistent with previous reports suggesting that increased diastolic RyR2 Ca 2ϩ leak impairs cardiac contractility because of a secondary decrease in SR Ca 2ϩ loading. Recent clinical studies provided further evidence that genetic defects in the RyR2 gene may predispose patients toward -CaMKII-HDAC pathways. 5 Local IP 3 R-mediated Ca 2ϩ release can activate CaMKII associated with IP 3 R in the nuclear envelope. Activation of CaMKII (or protein kinase D) causes HDAC phosphorylation and nuclear export. This relieves HDAC-dependent suppression of myocyte enhancer factor 2 (MEF2)-driven transcription. During pressure overload, RyR2-dependent SR Ca 2ϩ leak may activate the prohypertrophic CaN/NFAT pathway. 9 CaN is activated by Ca 2ϩ -CaM and can dephosphorylate NFAT. NFAT is then translocated to the nucleus, where, along with the transcription factor GATA, it can stimulate the transcription of genes contributing to hypertrophy. P indicates phosphorylation; GPCR, G protein-coupled receptors; and G␣ and ␤␥ are subunits of the G protein Gq. PLC denotes phospholipase C. PKC and PKD are protein kinase C and D, respectively. the development of hypertrophic cardiomyopathy and HF. 10 
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